FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2922018236> ?p ?o ?g. }

• W2922018236 abstract "The number of new cases of dementia is projected to rise significantly over the next decade. Thus, there is a pressing need for accurate tools to detect cognitive impairment in routine clinical practice. The Addenbrooke's Cognitive Examination III (ACE-III), and the mini-ACE are brief, bedside cognitive screens that have previously reported good sensitivity and specificity. The quality and quantity of this evidence has not, however, been robustly investigated.To assess the diagnostic test accuracy of the ACE-III and mini-ACE for the detection of dementia, dementia sub-types, and mild cognitive impairment (MCI) at published thresholds in primary, secondary, and community care settings in patients presenting with, or at high risk of, cognitive decline.We performed the search for this review on 13 February 2019. We searched MEDLINE (OvidSP), Embase (OvidSP), BIOSIS Previews (ISI Web of Knowledge), Web of Science Core Collection (ISI Web of Knowledge), PsycINFO (OvidSP), and LILACS (BIREME). We applied no language or date restrictions to the electronic searches; and to maximise sensitivity we did not use methodological filters. The search yielded 5655 records, of which 2937 remained after we removed duplicates. We identified a further four articles through PubMed 'related articles'. We found no additional records through reference list citation searching, or grey literature.Cross-sectional studies investigating the accuracy of the ACE-III or mini-ACE in patients presenting with, or at high risk of, cognitive decline were suitable for inclusion. We excluded case-control, delayed verification and longitudinal studies, and studies which investigated a secondary cause of dementia. We did not restrict studies by language; and we included those with pre-specified thresholds (88 and 82 for the ACE-III, and 21 or 25 for the mini-ACE).We extracted information on study and participant characteristics and used information on dementia and MCI prevalence, sensitivity, specificity, and sample size to generate 2×2 tables in Review Manager 5. We assessed methodological quality of included studies using the QUADAS-2 tool; and we assessed the quality of study reporting with the STARDdem tool. Due to significant heterogeneity in the included studies and an insufficient number of studies, we did not perform meta-analyses.This review identified seven studies (1711 participants in total) of cross-sectional design, four examining the accuracy of the ACE-III, and three of the mini-ACE. Overall, the majority of studies were at low or unclear risk of bias and applicability on quality assessment. Studies were at high risk of bias for the index test (n = 4) and reference standard (n = 2). Study reporting was variable across the included studies. No studies investigated dementia sub-types. The ACE-III had variable sensitivity across thresholds and patient populations (range for dementia at 82 and 88: 82% to 97%, n = 2; range for MCI at 88: 75% to 77%, n = 2), but with more variability in specificity (range for dementia: 4% to 77%, n = 2; range for MCI: 89% to 92%, n = 2). Similarly, sensitivity of the mini-ACE was variable (range for dementia at 21 and 25: 70% to 99%, n = 3; range for MCI at 21 and 25: 64% to 95%, n = 3) but with more variability specificity (range for dementia: 32% to 100%, n = 3; range for MCI: 46% to 79%, n = 3). We identified no studies in primary care populations: four studies were conducted in outpatient clinics, one study in an in-patient setting, and in two studies the settings were unclear.There is insufficient information in terms of both quality and quantity to recommend the use of either the ACE-III or mini-ACE for the screening of dementia or MCI in patients presenting with, or at high risk of, cognitive decline. No studies were conducted in a primary care setting so the accuracy of the ACE-III and mini-ACE in this setting are not known. Lower thresholds (82 for the ACE-III, and 21 for the mini-ACE) provide better specificity with acceptable sensitivity and may provide better clinical utility. The ACE-III and mini-ACE should only be used to support the diagnosis as an adjunct to a full clinical assessment. Further research is needed to determine the utility of the ACE-III and mini-ACE for the detection of dementia, dementia sub-types, and MCI. Specifically, the optimal thresholds for detection need to be determined in a variety of settings (primary care, secondary care (inpatient and outpatient), and community services), prevalences, and languages." @default.
• W2922018236 created "2019-03-22" @default.
• W2922018236 creator A5004500079 @default.
• W2922018236 creator A5045343269 @default.
• W2922018236 creator A5046012456 @default.
• W2922018236 creator A5050045927 @default.
• W2922018236 creator A5063632698 @default.
• W2922018236 creator A5079241292 @default.
• W2922018236 creator A5090549322 @default.
• W2922018236 date "2019-12-17" @default.
• W2922018236 modified "2023-10-13" @default.
• W2922018236 title "Addenbrooke’s Cognitive Examination III (ACE-III) and mini-ACE for the detection of dementia and mild cognitive impairment" @default.
• W2922018236 cites W1512044870 @default.
• W2922018236 cites W1530833367 @default.
• W2922018236 cites W1553319073 @default.
• W2922018236 cites W1559001474 @default.
• W2922018236 cites W1608129092 @default.
• W2922018236 cites W1726357000 @default.
• W2922018236 cites W1831873710 @default.
• W2922018236 cites W1895894047 @default.
• W2922018236 cites W1901951544 @default.
• W2922018236 cites W1910549955 @default.
• W2922018236 cites W191923870 @default.
• W2922018236 cites W1962263973 @default.
• W2922018236 cites W1965229261 @default.
• W2922018236 cites W1968634965 @default.
• W2922018236 cites W1984757623 @default.
• W2922018236 cites W1996330824 @default.
• W2922018236 cites W1999887188 @default.
• W2922018236 cites W2003950361 @default.
• W2922018236 cites W2010681077 @default.
• W2922018236 cites W2016656479 @default.
• W2922018236 cites W2018317802 @default.
• W2922018236 cites W2028436804 @default.
• W2922018236 cites W2030351137 @default.
• W2922018236 cites W2043522411 @default.
• W2922018236 cites W2058161128 @default.
• W2922018236 cites W2077113245 @default.
• W2922018236 cites W2084627444 @default.
• W2922018236 cites W2107638293 @default.
• W2922018236 cites W2112150247 @default.
• W2922018236 cites W2115017507 @default.
• W2922018236 cites W2123979895 @default.
• W2922018236 cites W2126332519 @default.
• W2922018236 cites W2128030851 @default.
• W2922018236 cites W2141470005 @default.
• W2922018236 cites W2149721272 @default.
• W2922018236 cites W2151989011 @default.
• W2922018236 cites W2156220037 @default.
• W2922018236 cites W2161341729 @default.
• W2922018236 cites W2165758561 @default.
• W2922018236 cites W2277613887 @default.
• W2922018236 cites W2281498324 @default.
• W2922018236 cites W2285286766 @default.
• W2922018236 cites W2309575153 @default.
• W2922018236 cites W2404472540 @default.
• W2922018236 cites W2511488406 @default.
• W2922018236 cites W2560539664 @default.
• W2922018236 cites W2584173197 @default.
• W2922018236 cites W2591983815 @default.
• W2922018236 cites W2619097621 @default.
• W2922018236 cites W2753434084 @default.
• W2922018236 cites W2756130101 @default.
• W2922018236 cites W2856566048 @default.
• W2922018236 cites W2939987918 @default.
• W2922018236 cites W2946408012 @default.
• W2922018236 cites W2946953725 @default.
• W2922018236 cites W2958248145 @default.
• W2922018236 cites W4210340856 @default.
• W2922018236 cites W4247665917 @default.
• W2922018236 cites W4255106309 @default.
• W2922018236 cites W4298428465 @default.
• W2922018236 cites W74129954 @default.
• W2922018236 doi "https://doi.org/10.1002/14651858.cd013282.pub2" @default.
• W2922018236 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6916534" @default.
• W2922018236 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31846066" @default.
• W2922018236 hasPublicationYear "2019" @default.
• W2922018236 type Work @default.
• W2922018236 sameAs 2922018236 @default.
• W2922018236 citedByCount "22" @default.
• W2922018236 countsByYear W29220182362020 @default.
• W2922018236 countsByYear W29220182362021 @default.
• W2922018236 countsByYear W29220182362022 @default.
• W2922018236 countsByYear W29220182362023 @default.
• W2922018236 crossrefType "journal-article" @default.
• W2922018236 hasAuthorship W2922018236A5004500079 @default.
• W2922018236 hasAuthorship W2922018236A5045343269 @default.
• W2922018236 hasAuthorship W2922018236A5046012456 @default.
• W2922018236 hasAuthorship W2922018236A5050045927 @default.
• W2922018236 hasAuthorship W2922018236A5063632698 @default.
• W2922018236 hasAuthorship W2922018236A5079241292 @default.
• W2922018236 hasAuthorship W2922018236A5090549322 @default.
• W2922018236 hasBestOaLocation W29220182362 @default.
• W2922018236 hasConcept C118552586 @default.
• W2922018236 hasConcept C126322002 @default.
• W2922018236 hasConcept C169900460 @default.
• W2922018236 hasConcept C17744445 @default.
• W2922018236 hasConcept C199539241 @default.
• W2922018236 hasConcept C2779134260 @default.
• W2922018236 hasConcept C2779473830 @default.

• next